COMMUNIQUÉS West-GlobeNewswire

assessURhealth, LLC Partners with athenahealth’s ‘More Disruption Please’ Program to Enhance Access to Mental and Behavioral Health Screening Tools

12/12/2017 - 14:01

Tampa, FL, Dec. 12, 2017 (GLOBE NEWSWIRE) -- assessURhealth, LLC , a provider of mental and behavioral health screening software, today announced a partnership with athenahealth , Inc. through athenahealth’s ‘ More [...]

scPharmaceuticals Inc. to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference

12/12/2017 - 14:00

BURLINGTON, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH ), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused [...]

Two Centers from The US Oncology Network Adopt iCAD’s Xoft Electronic Brachytherapy System for Treatment of Early-Stage Non-Melanoma Skin Cancer

12/12/2017 - 14:00

Prominent cancer centers expand portfolio of patient-centric treatment solutions with Xoft’s innovative, painless, scar-free solution NASHUA, N.H., Dec. 12, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD ), a global [...]

New York eHealth Collaborative Selects HealthEC to Provide MIPS Reporting through its Qualified Clinical Data Registry Services

12/12/2017 - 14:00

PISCATAWAY, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- HealthEC today announced that it has been selected by the New York eHealth Collaborative (NYeC) to customize its Merit-based Incentive Payment System (MIPS) reporting [...]

VBI Vaccines to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference

12/12/2017 - 14:00

CAMBRIDGE, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV ) (TSX: VBV ) (VBI) today announced that Jeff Baxter, President and CEO, will present at the BMO Capital Markets Prescriptions for [...]

Aduro Biotech Provides Update on CRS-207 Programs

12/12/2017 - 14:00

BERKELEY, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ), a biopharmaceutical company with three distinct immunotherapy technologies, today provided an update on its clinical development [...]

Ohr Pharmaceutical to Announce Fiscal Fourth Quarter & Year End 2017 Results on Friday, December 15

12/12/2017 - 14:00

NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP ), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that it will report [...]

Mersana Announces First Patient Dosed with XMT-1536 in Phase 1 Study in Patients with NaPi2b-Expressing Tumors

12/12/2017 - 14:00

Trial to Study Patients in Ovarian, NSCLC and Other Cancers XMT-1536 is Second Dolaflexin Antibody Drug Conjugate to Enter Clinical Trials CAMBRIDGE, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. ( [...]

Innovation Pharmaceuticals Granted European Patent for Brilacidin in the Prevention of Oral Mucositis

12/12/2017 - 14:00

BEVERLY, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today that the European Patent Office has granted a [...]

ABLYNX REPORTS ADDITIONAL CLINICALLY IMPORTANT BENEFITS OF CAPLACIZUMAB FROM ITS PHASE III HERCULES STUDY IN ACQUIRED TTP

12/12/2017 - 13:41

Additional results from the Phase III HERCULES study showed that treatment with caplacizumab resulted in: 38% relative reduction in the number of days of plasma exchange (PEX) 41% relative reduction in the volume of [...]

Corium to Join NASDAQ Biotechnology Index

12/12/2017 - 13:30

MENLO PARK, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]

Geron Reports Imetelstat Presentations at American Society of Hematology Annual Meeting

12/12/2017 - 13:30

Imetelstat Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes (MDS) Presented Analyst and Investor Meeting and Webcast at 8:30 a.m. ET on December 19, 2017 MENLO PARK, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE [...]

Actinium Pharmaceuticals Highlights Promising Data From its AWE Program Featuring a Potent Actinium-225 Labeled Daratumumab Labeled ARC or Antibody Radio-Conjugate Presented at ASH Annual Meeting

12/12/2017 - 13:30

Higher cell death observed with Actinium-225 labeled daratumumab with up to ten-fold higher potency as compared to naked daratumuamb ARC of Daratumumab-Actinium-225 labeled with high yield, high stability and preserved [...]

Nature’s Recent Scientific Reports Publication Describes How Apabetalone May Be a Powerful Agent Against HIV-1

12/12/2017 - 13:30

CALGARY, Alberta, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX ) announced today that a recent Nature Scientific Reports has published a 12 page publication on BET ( [...]

Myriad’s BRACAnalysis CDx® Test Effectively Identified Metastatic Breast Cancer Patients with Improved Outcomes from Pfizer's PARP Inhibitor, Talazoparib

12/12/2017 - 13:05

SALT LAKE CITY, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, today announced that data from the EMBRACA trial showed Myriad’s [...]

Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting

12/12/2017 - 13:00

BERKELEY HEIGHTS, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) "Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target [...]

Tonix Pharmaceuticals Completes Positive Pre-IND Meeting with FDA for TNX-102 SL (Cyclobenzaprine HCI Sublingual Tablets) as a Clinical Candidate for Agitation in Alzheimer’s Disease

12/12/2017 - 13:00

NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), a company that is developing innovative pharmaceutical and biological products to address public health challenges [...]

P. (Laxmin) Laxminarain Appointed to Microbot Medical’s Board of Directors

12/12/2017 - 13:00

HINGHAM, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT ), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]

Emergent BioSolutions Awarded Department of National Defence Contract to Supply Anthrasil to the Canadian Government

12/12/2017 - 13:00

GAITHERSBURG, Md., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) today announced that it has been awarded a contract by the Department of National Defence (DND) valued at approximately $8 [...]